GOSSAMER BIO, INC. Increase (Decrease) in Other Operating Assets
GOSSAMER BIO, INC. (GOSS) reported Increase (Decrease) in Other Operating Assets of $21.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-13
- GOSSAMER BIO, INC. increase (decrease) in other operating assets for the quarter ending 2026-06-30 was $31.00K, a 57.53% decline year-over-year.
- GOSSAMER BIO, INC. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was -$10.00K, a 137.04% decline year-over-year.
- GOSSAMER BIO, INC. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was $1.00K.
- GOSSAMER BIO, INC. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was $24.00K, a 89.29% decline year-over-year.
- GOSSAMER BIO, INC. increase (decrease) in other operating assets for fiscal 2025 was $125.00K.
- GOSSAMER BIO, INC. increase (decrease) in other operating assets for fiscal 2024 was -$335.00K.
- GOSSAMER BIO, INC. increase (decrease) in other operating assets for fiscal 2023 was -$62.00K.
- GOSSAMER BIO, INC. increase (decrease) in other operating assets for fiscal 2022 was -$400.00K, a 854.72% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $21.00K 10-Q · filed 2026-08-13 | $22.00K derived: sum of 3 quarters · filed 2026-08-13 | $46.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$10.00K 10-Q · filed 2026-05-15 | -$9.00K derived: sum of 2 quarters · filed 2026-05-15 | $15.00K derived: sum of 3 quarters · filed 2026-05-15 | $88.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $25.00K derived: sum of 2 quarters · filed 2026-03-17 | $98.00K derived: sum of 3 quarters · filed 2026-08-13 | $125.00K 10-K · filed 2026-03-17 |
| 2025-09-30 | $24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $97.00K derived: sum of 2 quarters · filed 2026-08-13 | $124.00K 10-Q · filed 2025-11-05 | $124.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $73.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $100.00K 10-Q · filed 2026-08-13 | $100.00K derived: sum of 3 quarters · filed 2026-08-13 | $324.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $27.00K 10-Q · filed 2026-05-15 | $27.00K derived: sum of 2 quarters · filed 2026-05-15 | $251.00K derived: sum of 3 quarters · filed 2026-05-15 | -$303.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $224.00K derived: sum of 2 quarters · filed 2026-03-17 | -$330.00K derived: sum of 3 quarters · filed 2026-03-17 | -$335.00K 10-K · filed 2026-03-17 |
| 2024-09-30 | $224.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$330.00K derived: sum of 2 quarters · filed 2025-11-05 | -$335.00K 10-Q · filed 2025-11-05 | -$366.00K derived: sum of 4 quarters · filed 2026-03-17 |
| 2024-06-30 | -$554.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$559.00K 10-Q · filed 2025-08-05 | -$590.00K derived: sum of 3 quarters · filed 2026-03-17 | -$711.00K derived: sum of 4 quarters · filed 2026-03-17 |
| 2024-03-31 | -$5.00K 10-Q · filed 2025-05-15 | -$36.00K derived: sum of 2 quarters · filed 2026-03-17 | -$157.00K derived: sum of 3 quarters · filed 2026-03-17 | -$130.00K derived: sum of 4 quarters · filed 2026-03-17 |
| 2023-12-31 | -$31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$152.00K derived: sum of 2 quarters · filed 2026-03-17 | -$125.00K derived: sum of 3 quarters · filed 2026-03-17 | -$62.00K 10-K · filed 2026-03-17 |
| 2023-09-30 | -$121.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$94.00K derived: sum of 2 quarters · filed 2024-11-07 | -$31.00K 10-Q · filed 2024-11-07 | $20.00K derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-06-30 | $27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $90.00K 10-Q · filed 2024-08-12 | $141.00K derived: sum of 3 quarters · filed 2025-03-13 | -$484.00K derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-03-31 | $63.00K 10-Q · filed 2024-05-07 | $114.00K derived: sum of 2 quarters · filed 2025-03-13 | -$511.00K derived: sum of 3 quarters · filed 2025-03-13 | -$276.00K derived: sum of 4 quarters · filed 2025-03-13 |
| 2022-12-31 | $51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$574.00K derived: sum of 2 quarters · filed 2025-03-13 | -$339.00K derived: sum of 3 quarters · filed 2025-03-13 | -$400.00K 10-K · filed 2025-03-13 |
| 2022-09-30 | -$625.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$390.00K derived: sum of 2 quarters · filed 2023-11-09 | -$451.00K 10-Q · filed 2023-11-09 | -$485.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | $235.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $174.00K 10-Q · filed 2023-08-08 | $140.00K derived: sum of 3 quarters · filed 2024-03-05 | $184.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | -$61.00K 10-Q · filed 2023-05-09 | -$95.00K derived: sum of 2 quarters · filed 2024-03-05 | -$51.00K derived: sum of 3 quarters · filed 2024-03-05 | $8.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | -$34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $10.00K derived: sum of 2 quarters · filed 2024-03-05 | $69.00K derived: sum of 3 quarters · filed 2024-03-05 | $53.00K 10-K · filed 2024-03-05 |
| 2021-09-30 | $44.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $103.00K derived: sum of 2 quarters · filed 2022-11-03 | $87.00K 10-Q · filed 2022-11-03 | $253.00K derived: sum of 4 quarters · filed 2023-03-17 |
| 2021-06-30 | $59.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $43.00K 10-Q · filed 2022-08-09 | $209.00K derived: sum of 3 quarters · filed 2023-03-17 | $443.00K derived: sum of 4 quarters · filed 2023-03-17 |
| 2021-03-31 | -$16.00K 10-Q · filed 2022-05-10 | $150.00K derived: sum of 2 quarters · filed 2023-03-17 | $384.00K derived: sum of 3 quarters · filed 2023-03-17 | $377.00K derived: sum of 4 quarters · filed 2023-03-17 |
| 2020-12-31 | $166.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $400.00K derived: sum of 2 quarters · filed 2023-03-17 | $393.00K derived: sum of 3 quarters · filed 2023-03-17 | -$532.00K 10-K · filed 2023-03-17 |
| 2020-09-30 | $234.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $227.00K derived: sum of 2 quarters · filed 2021-11-08 | -$698.00K 10-Q · filed 2021-11-08 | -$526.00K derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-06-30 | -$7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$932.00K 10-Q · filed 2021-08-09 | -$760.00K derived: sum of 3 quarters · filed 2022-03-03 | -$740.00K derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-03-31 | -$925.00K 10-Q · filed 2021-05-06 | -$753.00K derived: sum of 2 quarters · filed 2022-03-03 | -$733.00K derived: sum of 3 quarters · filed 2022-03-03 | -$1.50M derived: sum of 4 quarters · filed 2022-03-03 |
| 2019-12-31 | $172.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $192.00K derived: sum of 2 quarters · filed 2022-03-03 | -$570.00K derived: sum of 3 quarters · filed 2022-03-03 | -$2.71M 10-K · filed 2022-03-03 |
| 2019-09-30 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$742.00K derived: sum of 2 quarters · filed 2020-11-10 | -$2.89M 10-Q · filed 2020-11-10 | -$3.13M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | -$762.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | -$2.91M 10-Q · filed 2020-08-11 | -$3.15M derived: sum of 3 quarters · filed 2021-02-26 | -$2.75M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | -$2.14M 10-Q · filed 2020-05-12 | -$2.38M derived: sum of 2 quarters · filed 2021-02-26 | -$1.99M derived: sum of 3 quarters · filed 2021-02-26 | -$1.99M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | -$239.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $159.00K derived: sum of 2 quarters · filed 2021-02-26 | $159.00K derived: sum of 3 quarters · filed 2021-02-26 | $584.00K 10-K · filed 2021-02-26 |
| 2018-09-30 | $398.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $398.00K derived: sum of 2 quarters · filed 2019-11-12 | $823.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $425.00K 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $425.00K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 |